home · filing · 0001104659-23-076373
8-K filed June 29, 2023, 7:59 PM ET
ticker ABBV
CIK 0001551152
leadership
confidence high
sentiment neutral
materiality 0.50
AbbVie appoints Robert A. Michael as President and COO effective June 29, 2023
AbbVie Inc.
Robert A. Michael appointed President and Chief Operating Officer effective June 29, 2023.
He will continue oversight of AbbVie's global commercial and financial operations.
New responsibilities include operations, human resources, business development, and corporate strategy.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-06-29
Filed June 29, 2023, 7:59 PM ET
Effective June 29, 2023, Robert A. Michael has been appointed President and Chief Operating Officer.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert A. Michael was appointed as President and Chief Operating Officer at AbbVie Inc..
Action appointed
Role President and Chief Operating Officer
Exact text from the filing
Effective June 29, 2023, Robert A. Michael has been appointed President and Chief Operating Officer.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-23-076373
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.